1-2 of 2
Miguel Quijada Álamo, BSc, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CRISPR/Cas9-Generated Models Uncover Therapeutic Vulnerabilities of Del(11q) Chronic Lymphocytic Leukemia Cells to Dual BCR and PARP Inhibition

Miguel Quijada Álamo, BSc, MSc, María Hernández-Sánchez, PhD, José Luis Ordóñez, PhD, Verónica Alonso Pérez, PhD, Ana E. Rodriguez, PhD, Ignacio García-Tuñón, PhD, Ana B Herrero, PhD, Laura San-Segundo, Michaela Gruber, MD PhD, Juan Luis García, PhD, Rocio Benito, PhD, Catherine J. Wu, MD, Jesús-María Hernández-Rivas, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 948.
https://doi.org/10.1182/blood-2018-99-116080
Published: 2018
Journal Articles

Chronic Lymphocytic Leukemia Patients with IGH Rearrangements Are Characterized By a Distinct Genetic Landscape with Prognostic Implications

Claudia Pérez Carretero, MSc, BSc, Maria Hernandez-Sanchez, Teresa Gonzalez, Miguel Quijada Álamo, BSc, MSc, Marta Martín Izquierdo, MSc, Jesus M Hernández-Sánchez, MSc, Sandra Santos-Mínguez, María-Jesús Vidal, Alfonso García de Coca, MD PhD, Carlos Aguilar, Manuel Vargas-Pabón, Sara Alonso, MD, Magdalena Sierra, Araceli Rubio-Martínez, Julio Dávila, José R Díaz-Valdés, Jose Antonio Queizan, Jose Angel Hernandez-Rivas, MD, Maria-Victoria Mateos, MD PhD, Rocio Benito, PhD, Ana E. Rodriguez, PhD, Jesús-María Hernández-Rivas, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3129.
https://doi.org/10.1182/blood-2018-99-115959
Published: 2018